APT · XBRL financial data

Alpha Pro Tech financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (APT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cost of goods and services sold	52,218	43,339	40,298	38,403	34,907	36,605
Gross profit	50,482	25,298	21,683	22,829	22,933	22,537
Selling, general and administrative	18,171	16,554	16,219	17,772	18,611	17,773
Total operating expenses	18,900	17,371	17,033	18,697	19,484	18,698
Operating income (loss)	31,582	7,927	4,650	4,132	3,449	3,839
Income tax expense (benefit)	5,162	1,744	1,113	1,236	1,091	1,138
Net income (loss)	27,086	6,756	3,282	4,189	3,929	3,531
Earnings per share, basic USD per share	2.01	0.51	0.26	0.35	0.35	0.34
Earnings per share, diluted USD per share	1.94	0.50	0.26	0.35	0.35	0.33
Weighted average shares, basic thousands of shares	13,450	13,226	12,714	11,856	11,138	10,445
Weighted average shares, diluted thousands of shares	13,972	13,499	12,781	11,856	11,235	10,550

Fiscal years (APT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	23,292	16,307	16,290	20,378	18,636	16,988
Accounts receivable	8,132	3,397	5,382	—	—	—
Inventory	16,749	24,969	24,397	20,131	22,733	23,598
Total current assets	55,303	52,999	52,562	53,064	50,639	52,520
Property and equipment, net	4,353	6,064	5,742	5,587	8,520	8,234
Right-of-use asset	3,535	2,648	1,725	4,810	8,714	7,775
Goodwill	55	55	55	55	55	55
Total assets	68,802	67,889	64,803	68,763	73,742	74,132
Accounts payable	1,983	528	674	802	1,283	2,005
Accrued liabilities	2,793	1,250	833	1,103	947	1,088
Total current liabilities	5,852	2,661	2,406	2,566	3,123	4,058
Lease liability, non-current	2,719	1,817	875	4,187	7,882	6,917
Total liabilities	8,782	5,269	4,045	7,195	11,508	11,654
Retained earnings	59,476	62,488	62,124	46,552	47,257	48,496
Total stockholders' equity	60,020	62,620	60,758	61,568	62,234	62,478
Total liabilities and equity	68,802	67,889	64,803	68,763	73,742	74,132
Common shares outstanding (cover page) thousands of shares	13,597	13,139	12,264	11,462	10,873	10,185

Fiscal years (APT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	27,086	6,756	3,282	4,189	3,929	3,531
Stock-based compensation	375	315	147	170	463	540
Depreciation and amortization	729	817	814	925	873	925
Net cash from operating activities	18,274	(480)	4,277	8,458	5,698	2,370
Purchases of property and equipment	1,135	2,524	492	792	3,806	639
Net cash from investing activities	(862)	(2,524)	—	(792)	(3,776)	(639)
Share repurchases	2,666	4,408	3,882	4,002	4,452	3,345
Net cash from financing activities	(668)	(3,981)	(3,802)	(3,578)	(3,664)	(3,379)
Net change in cash	16,744	(6,985)	(17)	4,088	(1,742)	(1,648)

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Alpha Pro Tech	18,901	not reported	2,213*	10.2M	—	Q2 FY26 10-QJun 30, 2026
Nuo Therapeutics	449	not reported	(236)*	48.4M	1.9 quarters	Q2 FY26 10-QJun 30, 2026
Carlsmed	46,244	not reported	(7,358)*	27.3M	9.5 quarters	Q2 FY26 10-QJun 30, 2026
Milestone Scientific	2,067	not reported	(585)*	88.7M	3.5 quarters	Q2 FY26 10-QJun 30, 2026
Vicarious Surgical	1,407	not reported	(6,325)	not reported	0.6 quarters	Q1 FY26 10-QMar 31, 2026
Hyperfine	43,458	3,904	(7,268)*	not reported	6.0 quarters	Q2 FY26 10-QJun 30, 2026
Shoulder Innovations	24,460	17,175	(7,392)*	20.8M	13.4 quarters	Q2 FY26 10-QJun 30, 2026
Xtant Medical Holdings	9,870	23,031	(7,308)*	140.3M	1.4 quarters	Q2 FY26 10-QJun 30, 2026
Modular Medical	3,920	not reported	(5,972)	8.2M	0.7 quarters	Q1 FY27 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.